Image source: https://s.aolcdn.com/dims-global/dims3/GLOB/legacy_thumbnail/788x525/quality/85/https://s.aolcdn.com/commerce/autodata/images/USC70FOV324D021003.jpg
The global pharmaceutical industry has seen a downturn in recent years because of the challenges and cost associated with pharmaceutical development, procrastination in drug development, etc. Clinical trials field is also faced with such challenges. Cases of failures, cost and delay are high. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry. Due to complex clinical trials and bygone data standardization methods, we need algorithms and lucrative strategies that will enhance the clinical trials outcomes. There are vast data collected across clinical trial process, the standardization of these data will turn into an opportunity for companies to trap the information and raise clinical trial design, patient recruitment, monitoring insights and augment decision-making.
One response to this can be CROs and pharmaceutical companies can together work on diverse and varied clinical trial activities, also in near future we require joint effort for fulfilling outsourcing requirements and providing effective clinical trials.
This conference will bring together the industry experts and leaders across pharmaceutical, biotechnological and CROs for brainstorming on Case studies on innovation, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises, methodologies in trial design and many more.
It gives us a great pleasure to welcoming you to the .
Key Highlights:
Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
Outsourcing strategies and models
Patient centric clinical trials
Real World Clinical Trial Strategies
Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
Clinical Technology and Driving Innovation
M-Health, Wearable and Consumer Technology
Artificial Intelligence Technology in Clinical trials
Patient Recruitment and Site selection
Keeping the Patients Informed After the Trial - Post-Clinical Trial closed communities
How to future proof your clinical operations
Data Quality & Technology
Big-Data and IoT in Clinical Trials
Clinical Data Strategy & Analytics
Implementing Risk Based Monitoring
Streamlining R&D and lower costs in clinical trials
Adaptive Trial Model
Clinical Trial Auditing
Key Speakers:
MODESTAS JARUTIS , Medical Manager , Roche
SHEULI PORKESS, Interim Executive Director Research, Medical & Innovation ,The Association of the British Pharmaceutical Industry (A.B.P.I.)
SARAH COOPER, Business Development Manager, NIHR Clinical Research Network
GJON MIRDITA, Head of Site Management, Key Markets, R&D Solutions NEMEA & CESE, QuintilesIMS
MOHAMAD FAUZI ZAKARIA, GCP Audit & Inspection Process, ClinOps QMS, Novo Nordisk
TAMZIN BLAGBROUGH, sourcing consultant, Eli Lilly
Attendees includes VPs, GMs, Directors, Heads and Managers of
CROs
Regulatory and pharmacovigilance
Clinical Quality Management
Monitoring/Site Management/Study Management
Clinical Outsourcing/Vendor Management/Third-Party Management
Patient Recruitment/Enrollment
Patient Organizations
Good Clinical Practice
Digital innovative strategic planning
Clinical trials and data management
Clinical innovation
Data storage and analysis
Contract outsourcing service providers
Health care professionals
Health IT professionals
IT consultants
Other Clinical Service Providers
